Navigation Links
Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
Date:10/15/2007

n this press release that are not a description of historical facts may be forward-looking statements. Forward-looking statements are only predictions based upon current expectations and involve known and unknown risks and uncertainties. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of release of the relevant information, unless explicitly stated otherwise. Actual results, performance or achievement could differ materially from those expressed in, or implied by, Neuromed's forward-looking statements due to the risks and uncertainties inherent in Neuromed's business including, without limitation, statements about: the progress and timing of its clinical trials; difficulties or delays in development, testing, obtaining regulatory approval, producing and marketing its products; unexpected adverse side effects or inadequate therapeutic efficacy of its products that could delay or prevent product development or commercialization, or that could result in recalls or product liability claims; the scope and validity of patent protection for its products; competition from other pharmaceutical or biotechnology companies; and its ability to obtain additional financing to support its operations. Neuromed does not assume any obligation to update any forward-looking statements.

CONTACT: Julie Jang, Director, Communications, Neuromed Pharmaceuticals, Phone: (604) 909-2547, Email: jjang@neuromed.com


'/>"/>
SOURCE Neuromed Pharmaceuticals Ltd.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Special proteins to fight TB identified
2. Visually impaired prefer specially enhanced TV
3. Rural Canadians travel far for specialists: study
4. Special proteins to fight TB identified
5. Skin specialist advise on cellulite
6. Specialist care convalesces intensive care survival
7. Specialist surgeon not imperative in melanoma
8. Chronic back pain may be relieved by special physiotherapy
9. Treating Dental Problems Of Abused Children Need Special Care
10. Specialized Clinics For Manipurs AIDS Patients
11. Credentials Of Specialists Need To Be Checked
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2008)...eds of thousands of homeless forced to migrate nor...le so far with water, rice, survival ... /PRNewswire-FirstCall/ -- The lives of,thousands ... scramble out,of the shattered Irrawaddy Delta to ...sment of 26 shelters across the Myaung Mya region ...
(Date:5/11/2008)... can be bought over the counter and safely used at...) -- When you,re doing your spring cleaning, don,t...p and easy way for people with spring allergies, n...to get relief, says Dr. Melissa Pynnonen, co-direc...professor in the University of Michigan,s departme...
(Date:5/10/2008)...os need to play smart to avoid devastating vision ...0 (HealthDay News) -- Every year in the United Sta... injuries, says the American Academy of Ophthalmol... appropriate, sports-specific eye protection prope...s made from polycarbonate materials offer the high...
(Date:5/9/2008)...ARBARA, Calif., May 9 /PRNewswire-USNewsire/ -- U....upplies to help victims of,the Cyclone Nargis in M...irect Relief International, to ensure that the aid...it most., "It,s important to remember the complet...nmar starts with the people and organizations that...
Breaking Medicine News(10 mins):Health News:Crisis in Myanmar Relief Camps: Mass Exodus Sets Stage for Public Health Emergency 2Health News:Nasal Irrigation Can Help Fight Spring Allergies 2Health News:Protective Eyewear Key to Sports Safety 2Health News:Direct Relief's Corporate Partners Key to Aiding Cyclone Victims 2
Karnataka Pharmacy Gets Licence to Produce Medicines from White Arecanut
...ement, communication and professionalism are the k... guide junior doctors //through their early years ...ian Curriculum Framework for Junior Doctors by Dr ...iculum, and colleagues, is published in the latest...
...s in the US are increasingly opting for plastic su...//. The pressure to alter one's features and body...nity in America, observers say. But the minorities...ding to a survey by the American Society of Plasti...
...and Drug Administration (FDA) today announced that...re used to treat Parkinson’s disease, will volunta...of the risk of serious damage to patients’ heart v...re Permax, the trade name for pergolide marketed b...
Other Medicine News:Health News:Guiding Hand For Junior Doctors 2Health News:Asians in US Increasingly Undergoing Plastic Surgery to Look White 2Health News:FDA Announces Voluntary Withdrawal of Pergolide Products 2
(Date:5/9/2008)...opia,s development of early pipeline cancer drug c...e-FirstCall/ -- Cytopia Limited,(ASX: CYT) today a...rug,discovery and development collaboration with C...erages Cytopia,s early stage drug discovery pipeli...peutics that is one of the,fastest growing segment...
(Date:5/8/2008)...ay 8 /- The Cancer Research Alliance,...op cancer centers, is asking,303 million Americans...1 to,cancer research efforts this Mother,s Day thr...inite Power of One(TM)" has two key goals:,to acti...ir own hands by,joining together to exercise their...
(Date:5/8/2008)... Provides "Blueprint" to Produce Therapeutic Prote... 8 /PRNewswire-USNewswire/ -- Using gene,therapy, ...oteins through,skin flaps placed on cancerous tumo...lume, according to a study in the May issue of Pla...edical journal of the American,Society of Plastic ...
(Date:5/8/2008)...N, Del., May 8 /- AstraZene... supplemental New Drug Application,(sNDA) to the U...L XR(TM),(quetiapine fumarate) Extended-Release Ta...lized anxiety disorder (GAD), including maintenanc...oval has been sought for an,atypical antipsychotic...
Breaking Medicine Technology:Cytopia Announces Novel Anti-Cancer Drug Development Collaboration 2Cytopia Announces Novel Anti-Cancer Drug Development Collaboration 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 2Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 2AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 5AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 6AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 7AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 8Cervix Length at Mid Pregnancy May Predict C Section Risk 15225 1Cervix Length at Mid Pregnancy May Predict C Section Risk 15225 2Cervix Length at Mid Pregnancy May Predict C Section Risk 15225 3Dental chair a possible source of neurotoxic mercury waste 2633 1Dental chair a possible source of neurotoxic mercury waste 2633 2Abdominal Fat Boosts Dementia Risk 15219 1Abdominal Fat Boosts Dementia Risk 15219 2Abdominal Fat Boosts Dementia Risk 15219 3Emageon Receives Best in KLAS Cardiology PACS Award 15216 1Emageon Receives Best in KLAS Cardiology PACS Award 15216 2
... July 06, 2007 /PRNewswire-FirstCall/ --,Genzyme C...of two,Phase 3 clinical studies to assess the safe...ional, non-antibiotic, polymer,therapy for patient...CDAD). The second Phase 3 study of tolevamer liqui... this year. , In this first Phase 3 study known as...
...d--(BUSINESS WIRE)--Jul 9, 2007 - ZIOPHARM,Oncolog...erim data,from an ongoing phase II trial of ZIO-20...ed sarcoma patients was presented at the,European ...ly 5-8,2007 in Lugano, Switzerland. The abstract ...vanced Sarcoma," was presented by,Rashmi Chugh, MD...
Other Medicine Technology:Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 2Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 3Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 4Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: